Dr Madhu DIKSHIT
Dr Madhu Dikshit, a leading scientist in the country, has made significant contributions to the general area of Molecular Pharmacology with special emphasis on redox/NO biology and metabolism. Dr. Dikshit has impacted the area of neutrophil biology by enhancing our understanding that how nitric oxide modulates neutrophil differentiation, survival, free radical generation, NETosis, chemotaxis, and microbicidal activity. She has systematically investigated the role of iNOS in metabolic regulations and insulin sensitivity.
She also initiated and led the team for anti-thrombotic drug discovery at CDRI from which one of the NCEs has received DCGI permission for a Phase I clinical trial. At THSTI, she initiated a program on drug and biomarker discovery in the area of fatty liver disease and has made significant contributions. During the Covid-19 pandemic under a DBT-AYUSH project, she undertook the preclinical and pharmacokinetic evaluations of select AYUSH herbal extracts/formulations for mitigating SARS- CoV2 and associated pathologies.
Dr. Dikshit has published more than 200 well-cited papers, 25 reviews in peer-reviewed journals, edited three books, has eight patents, and has supervised 37 Ph.D., 10 MD theses, and a good number of graduate students.